Publication Date
6-1-2016
Journal
The Texas Heart Journal
DOI
10.14503/THIJ-15-5080
PMID
27303241
Publication Date(s)
June 2016
Language
English
PMCID
PMC4894704
PubMedCentral® Posted Date
6-1-2016
PubMedCentral® Full Text Version
Post-Print
Published Open-Access
yes
Keywords
Arteriovenous shunt, surgical/methods; blood vessel prosthesis implantation/methods; cardiac catheterization/instrumentation; cyanosis/therapy; heart septal defects, atrial/therapy; percutaneous coronary intervention/instrumentation/methods; prosthesis design; pulmonary artery/surgery; septal occluder device; treatment outcome; ventricular function, right
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Abstract
When total correction is not possible in infants who have a cyanotic congenital heart disease, creation of a palliative aortopulmonary shunt is essential. A central aortopulmonary shunt is preferable, because of its technical and hemodynamic advantages. Overcirculation, thrombosis, and stenosis of the shunt are the main postoperative sequelae that necessitate urgent reintervention. Percutaneous transcatheter closure of aortopulmonary shunts can eliminate the need for reoperation and substantially decrease postoperative morbidity and mortality rates. We report our successful transcatheter closures of central aortopulmonary shunts in a 3-month-old infant and a 15-year-old girl, with use of an Amplatzer Duct Occluder II and an Amplatzer Vascular Plug I, respectively. To our knowledge, this is the first report of the transcatheter closure of central aortopulmonary shunts with these 2 devices.